Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Work In Process (2016 - 2025)

Historic Work In Process for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to $270000.0.

  • Standard Biotools' Work In Process fell 8267.01% to $270000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $270000.0, marking a year-over-year decrease of 8267.01%. This contributed to the annual value of $443000.0 for FY2024, which is 5709.22% up from last year.
  • Standard Biotools' Work In Process amounted to $270000.0 in Q3 2025, which was down 8267.01% from $414000.0 recorded in Q2 2025.
  • Standard Biotools' Work In Process' 5-year high stood at $28.9 million during Q1 2025, with a 5-year trough of $270000.0 in Q3 2025.
  • In the last 5 years, Standard Biotools' Work In Process had a median value of $655000.0 in 2024 and averaged $2.2 million.
  • The largest annual percentage gain for Standard Biotools' Work In Process in the last 5 years was 431038.17% (2025), contrasted with its biggest fall of 8267.01% (2025).
  • Over the past 5 years, Standard Biotools' Work In Process (Quarter) stood at $867000.0 in 2021, then grew by 9.0% to $945000.0 in 2022, then crashed by 70.16% to $282000.0 in 2023, then skyrocketed by 57.09% to $443000.0 in 2024, then crashed by 39.05% to $270000.0 in 2025.
  • Its last three reported values are $270000.0 in Q3 2025, $414000.0 for Q2 2025, and $28.9 million during Q1 2025.